Form 6-K Gentium S.p.A. For: Nov 09
More News related to GENT
- Gentium Announces Presentation of Defibrotide Clinical Data at the American Society of Hematology Annual Meeting
- Gentium Announces New Board of Directors and Interim CEO
- Unusual 11 Mid-Day Movers 8/19: SPDE, CERS, OTIX, ISR, AXL Higher; GENT, PSTI, PLAB, LFT Lower
- Gentium (GENT) Reports Top Line Results from the Phase III Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease
- Loeb's Third Point Buys Into Starwood (HOT) and Tibco (TIBX), Dumps Yahoo! (YHOO)
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6592274
Filed on: November 9, 2009
Related Categories
SEC FilingsStocks Mentioned
+0.05Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
